Open AccessClinical Impact of GB Virus C Viremia on Patients with HIV Type 1 Infection in the Era of Highly Active Antiretroviral Therapy
Author(s) -
WangHuei Sheng,
ChienChing Hung,
R.-J. Wu,
JannTay Wang,
PeiJer Chen,
ShanChwen Chang,
JiaHorng Kao
Publication year - 2007
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/511037
Subject(s) - viremia , medicine , gb virus c , viral load , immunology , hepatitis c virus , epidemiology , virology , gastroenterology , flaviviridae , virus
The influence of GB virus C (GBV-C) viremia on clinical outcomes of patients with human immunodeficiency virus type 1 (HIV-1) infection remains controversial in the era of highly active antiretroviral therapy (HAART).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom